AU1453792A - Targeting complex mediated immunogenicity - Google Patents

Targeting complex mediated immunogenicity

Info

Publication number
AU1453792A
AU1453792A AU14537/92A AU1453792A AU1453792A AU 1453792 A AU1453792 A AU 1453792A AU 14537/92 A AU14537/92 A AU 14537/92A AU 1453792 A AU1453792 A AU 1453792A AU 1453792 A AU1453792 A AU 1453792A
Authority
AU
Australia
Prior art keywords
targeting complex
complex mediated
mediated immunogenicity
immunogenicity
targeting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14537/92A
Inventor
Peter Schultz
Kevan M Shokat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU1453792A publication Critical patent/AU1453792A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6425Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU14537/92A 1991-02-27 1992-02-26 Targeting complex mediated immunogenicity Abandoned AU1453792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66170291A 1991-02-27 1991-02-27
US661702 1991-02-27

Publications (1)

Publication Number Publication Date
AU1453792A true AU1453792A (en) 1992-10-06

Family

ID=24654742

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14537/92A Abandoned AU1453792A (en) 1991-02-27 1992-02-26 Targeting complex mediated immunogenicity

Country Status (2)

Country Link
AU (1) AU1453792A (en)
WO (1) WO1992015326A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0758394B1 (en) 1994-05-02 2002-11-20 Bernd Groner Bifunctional protein, preparation and use
US9181224B2 (en) * 2009-10-13 2015-11-10 Yale University Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2622444B1 (en) * 1987-10-30 1990-08-03 Pasteur Institut APPLICATION OF DINITRO-TRINITROPHENYL AND ITS DERIVATIVES OR ANTI-NITROPHENYL ANTIBODIES TO MODIFYING THE INTERACTION BETWEEN HOST SENSITIVE CELLS AND A PATHOGENIC AGENT

Also Published As

Publication number Publication date
WO1992015326A1 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
AU5457096A (en) Gene-transfer-mediated angiogenesis therapy
AU1219292A (en) Inhaler
AU6018194A (en) Easy intubator
AU8253791A (en) Delivery catheter
AU1768192A (en) Rna delivery vector
AU2421192A (en) Inhaler
AU8554691A (en) Improved formulations
AU3278793A (en) Multispray nozzle
AU1823492A (en) Imidazodiazepines
AU2121092A (en) Benzodioxanderivate
AU1930992A (en) Pyrrolopyrazines
AU1782292A (en) Gridbeam
AU2135292A (en) Cyanophenylpyrroles
AU2838192A (en) Catheter
AU8174791A (en) Burner nozzle
AU1652492A (en) Game
AU1428792A (en) Torsionally stable guidewire
AU1556892A (en) 2-substituted-2-imidazolines
AU2636292A (en) Anti-alpha6-integrin-antibodies
AU7617791A (en) Recombinant immunocastration vaccine
AU1080292A (en) Ige-receptor-antibodies
AU7719791A (en) Therapeutic product
AU2787092A (en) Toy
AU2586192A (en) Imaginograph
AU1752492A (en) Diamino-alpha-alkylstilbenes